RICE-ibrutinib in Relapsed DLBCL

Clinical trial NCT02955628 · UNKNOWN

Trial details

NCT number: NCT02955628
Sponsor: Singapore General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Diffuse Large B-Cell Lymphoma Recurrent

Start date: 2016-12-13
Primary completion: 2023-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.